$CNFN
CFN Enterprises Inc.

2017 Q1 Form 10-Q Financial Statement

#000143774917008762 Filed on May 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $5.957M $5.864M
YoY Change 1.58% 12.78%
Cost Of Revenue $1.545M $1.932M
YoY Change -20.02% 46.62%
Gross Profit $4.411M $3.932M
YoY Change 12.19% 1.29%
Gross Profit Margin 74.06% 67.05%
Selling, General & Admin $1.926M $2.289M
YoY Change -15.84% -6.75%
% of Gross Profit 43.67% 58.21%
Research & Development $1.043M $1.030M
YoY Change 1.23% 17.72%
% of Gross Profit 23.65% 26.21%
Depreciation & Amortization $169.0K $264.1K
YoY Change -35.99% -34.47%
% of Gross Profit 3.83% 6.72%
Operating Expenses $4.186M $4.312M
YoY Change -2.93% -21.08%
Operating Profit $225.5K -$380.2K
YoY Change -159.33% -75.97%
Interest Expense -$280.0K -$200.0K
YoY Change 40.0% 1900.0%
% of Operating Profit -124.15%
Other Income/Expense, Net -$280.8K -$203.1K
YoY Change 38.24% 1542.33%
Pretax Income -$60.00K -$580.0K
YoY Change -89.66% -63.52%
Income Tax
% Of Pretax Income
Net Earnings -$55.22K -$583.2K
YoY Change -90.53% -63.42%
Net Earnings / Revenue -0.93% -9.95%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 65.26M 65.07M
Diluted Shares Outstanding 65.26M 65.07M

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $510.0K $1.080M
YoY Change -52.78% -27.52%
Cash & Equivalents $513.6K $1.081M
Short-Term Investments
Other Short-Term Assets $590.0K $220.0K
YoY Change 168.18% 0.0%
Inventory
Prepaid Expenses
Receivables $2.323M $2.094M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.425M $3.393M
YoY Change 0.95% -7.15%
LONG-TERM ASSETS
Property, Plant & Equipment $3.288M $2.163M
YoY Change 52.01% 49.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $103.4K $115.5K
YoY Change -10.52% -8.88%
Total Long-Term Assets $3.391M $2.278M
YoY Change 48.84% 28.58%
TOTAL ASSETS
Total Short-Term Assets $3.425M $3.393M
Total Long-Term Assets $3.391M $2.278M
Total Assets $6.816M $5.671M
YoY Change 20.19% 4.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.910M $2.410M
YoY Change -20.75% 41.76%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $450.0K $630.0K
YoY Change -28.57%
Long-Term Debt Due $2.220M $4.540M
YoY Change -51.1%
Total Short-Term Liabilities $4.671M $7.600M
YoY Change -38.54% 328.01%
LONG-TERM LIABILITIES
Long-Term Debt $4.520M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.381M
YoY Change
Total Long-Term Liabilities $1.381M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.671M $7.600M
Total Long-Term Liabilities $1.381M $0.00
Total Liabilities $10.57M $7.603M
YoY Change 38.99% 33.96%
SHAREHOLDERS EQUITY
Retained Earnings -$29.17M -$25.85M
YoY Change 12.86% 25.5%
Common Stock $65.28K $65.07K
YoY Change 0.33% 3.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.752M -$1.932M
YoY Change
Total Liabilities & Shareholders Equity $6.816M $5.671M
YoY Change 20.19% 4.52%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$55.22K -$583.2K
YoY Change -90.53% -63.42%
Depreciation, Depletion And Amortization $169.0K $264.1K
YoY Change -35.99% -34.47%
Cash From Operating Activities -$659.6K $218.4K
YoY Change -402.0% -151.69%
INVESTING ACTIVITIES
Capital Expenditures $9.799K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$510.0K -$470.0K
YoY Change 8.51% 161.11%
Cash From Investing Activities -$524.5K -$470.3K
YoY Change 11.51% 111.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.45K 432.2K
YoY Change -96.89% -57.19%
NET CHANGE
Cash From Operating Activities -659.6K 218.4K
Cash From Investing Activities -524.5K -470.3K
Cash From Financing Activities 13.45K 432.2K
Net Change In Cash -1.171M 180.3K
YoY Change -749.18% -50.56%
FREE CASH FLOW
Cash From Operating Activities -$659.6K $218.4K
Capital Expenditures $9.799K
Free Cash Flow -$669.4K $218.4K
YoY Change -406.48% -146.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 aclz Other Finance Fees
OtherFinanceFees
136155
CY2017Q1 aclz Cashless Exercise Of Options
CashlessExerciseOfOptions
2400000
CY2016Q1 aclz Cashless Exercise Of Options
CashlessExerciseOfOptions
0
CY2016Q4 aclz Common Stock Issued And Outstanding Percentage Decrease
CommonStockIssuedAndOutstandingPercentageDecrease
0.03
CY2017Q1 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
219700
CY2016Q1 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
441159
CY2017Q1 aclz Other Finance Fees
OtherFinanceFees
24125
CY2017Q1 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
CY2016Q1 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
CY2017Q1 aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
1707692
CY2017Q1 aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65262289
CY2016Q1 aclz Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
65069327
CY2017Q1 aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
16275714
CY2016Q1 aclz Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
18869637
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1910041
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2639008
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2322942
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2229610
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2749985
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2585072
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-73249
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77329
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25429569
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25211737
CY2017Q1 us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Advertising</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company expenses advertising costs as incurred.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Three-month periods ended</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">March 31,</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; WIDTH: 70%; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Advertising expense</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; WIDTH: 1%; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; WIDTH: 12%; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,416</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; WIDTH: 1%; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; WIDTH: 12%; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,326</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div>
CY2017Q1 us-gaap Advertising Expense
AdvertisingExpense
86416
CY2016Q1 us-gaap Advertising Expense
AdvertisingExpense
37326
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125867
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
284093
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
351921
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
349535
CY2017Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
59807
CY2016Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
138366
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
133573
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
189360
CY2017Q1 us-gaap Assets
Assets
6815805
CY2016Q4 us-gaap Assets
Assets
7393624
CY2017Q1 us-gaap Assets Current
AssetsCurrent
3424885
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4357924
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3762
CY2017Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3166000
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2784000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1680127
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
908095
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
513641
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1081221
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1166486
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
173126
CY2017Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65283042
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63415254
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63415254
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65283042
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63415254
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63415254
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
65282
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
63414
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-51144
CY2016Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-590429
CY2017Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
29372
CY2017Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000</div>.</div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. None of the Company&#x2019;s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div>&nbsp;&nbsp;The Company does not require any collateral from its customers.</div></div></div></div></div></div></div></div></div>
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
1545345
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
1932123
CY2016Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
43133
CY2017Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
383723
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
429769
CY2017Q1 us-gaap Deferred Revenue
DeferredRevenue
94033
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
53450
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
94033
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53450
CY2017Q1 us-gaap Depreciation
Depreciation
35455
CY2016Q1 us-gaap Depreciation
Depreciation
77313
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
169028
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
264080
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4080
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7188
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
381693
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y180D
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-902
CY2016Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
2200000
CY2017Q1 us-gaap Gross Profit
GrossProfit
4411379
CY2016Q1 us-gaap Gross Profit
GrossProfit
3931895
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-860096
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
178075
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
95718
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
281831
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40583
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9201
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
813
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9418
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
140115
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-22243
CY2017Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
280452
CY2016Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
212549
CY2017Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
196590
CY2016Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
67403
CY2017Q1 us-gaap Interest Paid
InterestPaid
196590
CY2016Q1 us-gaap Interest Paid
InterestPaid
67403
CY2017Q1 us-gaap Liabilities
Liabilities
10567623
CY2016Q4 us-gaap Liabilities
Liabilities
11313998
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6815805
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7393624
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4671014
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5238271
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6000000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3000000
CY2017Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2221312
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2038946
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
1700000
CY2017Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4515359
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4588227
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13452
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
432223
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-524458
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-470308
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-659560
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
218399
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-55224
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-583241
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55224
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-583241
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-280752
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-203090
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4185851
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
4312046
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
225528
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-380151
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103387
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102574
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4080
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-7188
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4080
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7188
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4080
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7188
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1381250
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1487500
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-300
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9459
CY2017Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
445628
CY2016Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
506867
CY2017Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2016Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
130000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9799
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
515454
CY2016Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
475000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
538302
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398187
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000
CY2016Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
625000
CY2017Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
795
CY2016Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4692
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-55224
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-583241
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6037518
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5518198
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3287533
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2933126
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2386
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20929
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
62777
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1043119
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1030456
CY2017Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
486548
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29173420
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29118196
CY2017Q1 us-gaap Revenues
Revenues
5956724
CY2016Q1 us-gaap Revenues
Revenues
5864018
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65262289
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65069327
CY2017Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65262289
CY2016Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65069327
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65262289
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.43
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.45
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10467500
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13125000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.43
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.38
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1216490
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
992878
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1926242
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2288712
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
257500
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20000
CY2017Q1 us-gaap Stock Issued1
StockIssued1
1868
CY2016Q1 us-gaap Stock Issued1
StockIssued1
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-3751818
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-3920374
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div></div></div></div></div></div>
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65069327

Files In Submission

Name View Source Status
0001437749-17-008762-index-headers.html Edgar Link pending
0001437749-17-008762-index.html Edgar Link pending
0001437749-17-008762.txt Edgar Link pending
0001437749-17-008762-xbrl.zip Edgar Link pending
aclz-20170331.xml Edgar Link completed
aclz-20170331.xsd Edgar Link pending
aclz-20170331_cal.xml Edgar Link unprocessable
aclz-20170331_def.xml Edgar Link unprocessable
aclz-20170331_lab.xml Edgar Link unprocessable
aclz-20170331_pre.xml Edgar Link unprocessable
aclz20170331_10q.htm Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending